Dr. Lataillade & BRIGHTE: It was a multicentre,
Post# of 148697
It was a multicentre, two-cohort, phase 3 trial, at 108 centres in 22 countries.
We just went from always wondering ---- is our trial size big enough?
To onboarding that level of experience & reputation.
Imagine what he's going to accomplish for our HIV programs.